Literature DB >> 21639805

Allosteric modulation of ATP-gated P2X receptor channels.

Claudio Coddou1, Stanko S Stojilkovic, J Pablo Huidobro-Toro.   

Abstract

Seven mammalian purinergic receptor subunits, denoted P2X1-P2X7, and several spliced forms of these subunits have been cloned. When heterologously expressed, these cDNAs encode ATP-gated non-selective cation channels organized as trimers. All activated receptors produce cell depolarization and promote Ca(2+) influx through their pores and indirectly by activating voltage-gated calcium channels. However, the biophysical and pharmacological properties of these receptors differ considerably, and the majority of these subunits are also capable of forming heterotrimers with other members of the P2X receptor family, which confers further different properties. These channels have three ATP binding domains, presumably located between neighboring subunits, and occupancy of at least two binding sites is needed for their activation. In addition to the orthosteric binding sites for ATP, these receptors have additional allosteric sites that modulate the agonist action at receptors, including sites for trace metals, protons, neurosteroids, reactive oxygen species and phosphoinositides. The allosteric regulation of P2X receptors is frequently receptor-specific and could be a useful tool to identify P2X members in native tissues and their roles in signaling. The focus of this review is on common and receptor-specific allosteric modulation of P2X receptors and the molecular base accounting for allosteric binding sites.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21639805      PMCID: PMC3647606          DOI: 10.1515/RNS.2011.014

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  193 in total

1.  [Studies on the crystal structure of ivermectin (H2B1a)].

Authors:  X Hu; J Gu; L Chen; Y HuangPu
Journal:  Yao Xue Xue Bao       Date:  1998-06

2.  ON THE HORMONAL ACTIVITY OF A STEROID COMPOUND.

Authors:  H Selye
Journal:  Science       Date:  1941-07-25       Impact factor: 47.728

3.  P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.

Authors:  A Nicke; H G Bäumert; J Rettinger; A Eichele; G Lambrecht; E Mutschler; G Schmalzing
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  Effects of neuroamines and divalent cations on cloned and mutated ATP-gated channels.

Authors:  K Nakazawa; Y Ohno
Journal:  Eur J Pharmacol       Date:  1997-04-23       Impact factor: 4.432

5.  Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects.

Authors:  A D Michel; W C Clay; S W Ng; S Roman; K Thompson; J P Condreay; M Hall; J Holbrook; D Livermore; S Senger
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

6.  Atypical P2X receptor pharmacology in two human osteoblast-like cell lines.

Authors:  S M Alqallaf; B A J Evans; E J Kidd
Journal:  Br J Pharmacol       Date:  2009-02-18       Impact factor: 8.739

7.  Opposite effects of zinc on human and rat P2X2 receptors.

Authors:  Rachel K Tittle; Richard I Hume
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

8.  P2X1 and P2X4 receptor currents in mouse macrophages.

Authors:  J A Sim; C-K Park; S B Oh; R J Evans; R A North
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739

9.  Cloning and functional expression of a brain G-protein-coupled ATP receptor.

Authors:  T E Webb; J Simon; B J Krishek; A N Bateson; T G Smart; B F King; G Burnstock; E A Barnard
Journal:  FEBS Lett       Date:  1993-06-14       Impact factor: 4.124

10.  Lack of evidence for direct phosphorylation of recombinantly expressed P2X(2) and P2X (3) receptors by protein kinase C.

Authors:  Cindy Franklin; Ursula Braam; Thomas Eisele; Günther Schmalzing; Ralf Hausmann
Journal:  Purinergic Signal       Date:  2007-09-06       Impact factor: 3.765

View more
  36 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

Review 3.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 4.  P2X receptors as drug targets.

Authors:  R Alan North; Michael F Jarvis
Journal:  Mol Pharmacol       Date:  2012-12-19       Impact factor: 4.436

Review 5.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

6.  Promising Therapeutic Potential of P2X7 Modulators.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2016-03-04       Impact factor: 4.345

7.  Druggable negative allosteric site of P2X3 receptors.

Authors:  Jin Wang; Yao Wang; Wen-Wen Cui; Yichen Huang; Yang Yang; Yan Liu; Wen-Shan Zhao; Xiao-Yang Cheng; Wang-Sheng Sun; Peng Cao; Michael X Zhu; Rui Wang; Motoyuki Hattori; Ye Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-19       Impact factor: 11.205

8.  High potency zinc modulation of human P2X2 receptors and low potency zinc modulation of rat P2X2 receptors share a common molecular mechanism.

Authors:  Sukanya Punthambaker; Jacob A Blum; Richard I Hume
Journal:  J Biol Chem       Date:  2012-05-03       Impact factor: 5.157

9.  Pharmacological dissection of the cellular mechanisms associated to the spontaneous and the mechanically stimulated ATP release by mesentery endothelial cells: roles of thrombin and TRPV.

Authors:  M Verónica Donoso; Felipe Hernández; Tania Villalón; Claudio Acuña-Castillo; J Pablo Huidobro-Toro
Journal:  Purinergic Signal       Date:  2018-01-19       Impact factor: 3.765

10.  Characterization of the antagonist actions of 5-BDBD at the rat P2X4 receptor.

Authors:  Claudio Coddou; Rodrigo Sandoval; María José Hevia; Stanko S Stojilkovic
Journal:  Neurosci Lett       Date:  2018-10-23       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.